All News #Library
Rare Diseases
Inhibrx Intends FDA Submission After Phase 2 Bone Cancer Win
24 Oct 2025 //
FIERCE BIOTECH
Sanofi`s $1.7B Bet Beats Csl`s Zemaira In Phase 2 Face-Off
22 Oct 2025 //
FIERCE BIOTECH
Inhibrx down 8% after announcing webcast for pathway for rare disease candidate
03 Oct 2022 //
SEEKINGALPHA

Market Place
Sourcing Support